DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence
Horning, Aaron M., Awe, Julius A., Wang, Chiou-Miin, Liu, Joseph, Lai, Zhao, Wang, Vickie Yao, Jadhav, Rohit R., Louie, Anna D., Lin, Chun-Lin, Kroczak, Tad, Chen, Yidong, Jin, Victor X., Abboud-Werner, Sherry L., Leach, Robin J., Hernandez, Javior, Thompson, Ian M., Saranchuk, Jeff, Drachenberg, Darrel, Chen, Chun-Liang, Mai, Sabine, Huang, Tim Hui-Ming
Published in The Prostate (01.11.2015)
Published in The Prostate (01.11.2015)
Get full text
Journal Article